{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:41:40Z","timestamp":1790253700275,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T00:00:00Z","timestamp":1456185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T00:00:00Z","timestamp":1456185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bipolar disorder is a highly heritable neuropsychiatric disorder affecting nearly 2.5% of the population. Prior genetic studies identified a panel of common and rare single-nucleotide polymorphisms associated with the disease that map to the first intron of the PDE10A gene. RNA sequencing of striatal brain tissue from bipolar and healthy control subjects identified a novel transcript of PDE10A, named PDE10A19, that codes for a PDE10A isoform with a unique N terminus. Genomic sequences that can encode the novel N terminus were conserved in other primates but not rodents. The RNA transcript was expressed at equal or greater levels in the human striatum compared with the two annotated transcripts, PDE10A1 and PDE10A2. The PDE10A19 transcript was detected in polysomal fractions; western blotting experiments confirmed that the RNA transcript is translated into protein. Immunocytochemistry studies using transfected mouse striatal and cortical neurons demonstrated that the PDE10A19 protein distributes to the cytosol, like PDE10A1, and unlike PDE10A2, which is associated with plasma membranes. Immunoprecipitation and immunocytochemical experiments revealed that the PDE10A19 isoform interacts physically with PDE10A2 and, when expressed at elevated levels, interferes with the plasma membrane localization of PDE10A2. These studies illustrate the complexity of PDE10A gene expression in the human brain and highlight the need to unravel the gene\u2019s complex and complete coding capabilities along with its transcriptional and translational regulation to guide the development of therapeutic agents that target the protein for the treatment of neuropsychiatric illness.<\/jats:p>","DOI":"10.1038\/tp.2016.3","type":"journal-article","created":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T15:11:33Z","timestamp":1456240293000},"page":"e742-e742","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Novel, primate-specific PDE10A isoform highlights gene expression complexity in human striatum with implications on the molecular pathology of bipolar disorder"],"prefix":"10.1038","volume":"6","author":[{"given":"C M","family":"MacMullen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Vick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Pacifico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Fallahi-Sichani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R L","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,23]]},"reference":[{"key":"BFtp20163_CR1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.neuroscience.2009.03.080","volume":"164","author":"JH Barnett","year":"2009","unstructured":"Barnett JH, Smoller JW . The genetics of bipolar disorder. Neuroscience 2009; 164: 331\u2013343.","journal-title":"Neuroscience"},{"key":"BFtp20163_CR2","first-page":"1","volume":"151","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 1994; 151: 1\u201336.","journal-title":"Am J Psychiatry"},{"key":"BFtp20163_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(02)07450-0","volume":"359","author":"B Muller-Oerlinghausen","year":"2002","unstructured":"Muller-Oerlinghausen B, Bergh\u00f6fer A, Bauer M . Bipolar disorder. Lancet 2002; 359: 241\u2013247.","journal-title":"Lancet"},{"key":"BFtp20163_CR4","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1136\/jmg.36.8.585","volume":"36","author":"N Craddock","year":"1999","unstructured":"Craddock N, Jones I . Genetics of Bipolar Disorder. J Med Genet 1999; 36: 585\u2013594.","journal-title":"J Med Genet"},{"key":"BFtp20163_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.tig.2008.12.002","volume":"25","author":"N Craddock","year":"2009","unstructured":"Craddock N, Sklar P . Genetics of bipolar disorder: successful start to a long journey. Trends Genet 2009; 25: 99\u2013105.","journal-title":"Trends Genet"},{"key":"BFtp20163_CR6","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/S0140-6736(13)60855-7","volume":"381","author":"N Craddock","year":"2013","unstructured":"Craddock N, Sklar P . Genetics of bipolar disorder. Lancet 2013; 381: 1654\u20131662.","journal-title":"Lancet"},{"key":"BFtp20163_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/jmg.2005.030718","volume":"42","author":"N Craddock","year":"2005","unstructured":"Craddock N, O\u2019Donovan MC, Owen MJ . The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J Med Genet 2005; 42: 193\u2013204.","journal-title":"J Med Genet"},{"key":"BFtp20163_CR8","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1001\/archpsyc.64.10.1180","volume":"64","author":"KR Merikangas","year":"2007","unstructured":"Merikangas KR, Ames M, Cui L, Stang PE, Ustun TB, Korff MV et al. The impact of comorbidity of mental and physical conditions on role disability in the US adult household population. Arch Gen Psychiatry 2007; 64: 1180\u20131188.","journal-title":"Arch Gen Psychiatry"},{"key":"BFtp20163_CR9","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1086\/491603","volume":"77","author":"M McQueen","year":"2005","unstructured":"McQueen M, Devlin B, Faraone S, Nimgaonkar V, Sklar P, Smoller J et al. Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet 2005; 77: 582\u2013595.","journal-title":"Am J Hum Genet"},{"key":"BFtp20163_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/sj.mp.4001012","volume":"7","author":"J Badner","year":"2002","unstructured":"Badner J, Gershon E . Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 2002; 7: 405\u2013411.","journal-title":"Mol Psychiatry"},{"key":"BFtp20163_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1086\/376547","volume":"73","author":"R Segurado","year":"2003","unstructured":"Segurado R, Detera-Wadleigh S, Levinson D, Lewis C, Gill M, Nurnberger JJ et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: bipolar disorder. Am J Hum Genet 2003; 73: 49\u201362.","journal-title":"Am J Hum Genet"},{"key":"BFtp20163_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/tp.2012.92","volume":"2","author":"M-L McDonald","year":"2012","unstructured":"McDonald M-L, MacMullen C, Liu D, Leal S, Davis R . Genetic association of cyclic AMP signaling genes with bipolar disorder. Transl Psychiatry 2012; 2: 1\u201310.","journal-title":"Transl Psychiatry"},{"key":"BFtp20163_CR13","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0022-3999(02)00426-9","volume":"53","author":"TD Gould","year":"2002","unstructured":"Gould TD, Manji HK . Signaling networks in the pathophysiology and treatment of mood disorders. J Psychosom Res 2002; 53: 687\u2013697.","journal-title":"J Psychosom Res"},{"key":"BFtp20163_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2147\/NDT.S2380","volume":"4","author":"Y Dwivedi","year":"2008","unstructured":"Dwivedi Y, Pandey GN . Adenylyl cyclase-cyclicAMP signaling in mood disorders: role of the crucial phosphorylating enzyme protein kinase A. Neuropsychiatr Dis Treat 2008; 4: 161\u2013176.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"BFtp20163_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1046\/j.1471-4159.1997.68010297.x","volume":"68","author":"S Rahman","year":"1997","unstructured":"Rahman S, Li P, Young L, Kofman O, Kish S, Warsh J . Reduced [3H]cyclic AMP binding in postmortem brain from subjects with bipolar affective disorder. J Neurochem 1997; 68: 297\u2013304.","journal-title":"J Neurochem"},{"key":"BFtp20163_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0165-0327(02)00463-9","volume":"79","author":"F Karege","year":"2004","unstructured":"Karege F, Schwald M, Papadimitriou P, Lachausse C, Ciss\u00e9 M . The cAMP-dependent protein kinase A and brain-derived neurotrophic factor expression in lymphoblast cells of bipolar affective disorder. J Affect Disord 2004; 79: 187\u2013192.","journal-title":"J Affect Disord"},{"key":"BFtp20163_CR17","doi-asserted-by":"publisher","first-page":"18438","DOI":"10.1074\/jbc.274.26.18438","volume":"274","author":"K Fujishige","year":"1999","unstructured":"Fujishige K, Kotera J, Michibata H, Yuasa K, Takebayashi S-i, Okumura K et al. Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A)*. J Biol Chem 1999; 274: 18438\u201318445.","journal-title":"J Biol Chem"},{"key":"BFtp20163_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0378-1119(99)00171-7","volume":"234","author":"K Loughney","year":"1999","unstructured":"Loughney K, Snyder P, Uher L, Rosman G, Ferguson K, Florio V . Isolation and characterization of PDE10A, a novel human 3\u2032, 5\u2032-cyclic nucleotide phosphodiesterase. Gene 1999; 234: 109\u2013117.","journal-title":"Gene"},{"key":"BFtp20163_CR19","doi-asserted-by":"publisher","first-page":"7071","DOI":"10.1073\/pnas.96.12.7071","volume":"96","author":"SH Soderling","year":"1999","unstructured":"Soderling SH, Bayuga SJ, Beavo JA . Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A. Proc Natl Acad Sci USA 1999; 96: 7071\u20137076.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtp20163_CR20","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1369\/jhc.6A6930.2006","volume":"54","author":"T Coskran","year":"2006","unstructured":"Coskran T, Morton D, Menniti F, Adamowicz W, Kleiman R, Ryan A et al. Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species. J Histochem Cytochem 2006; 54: 1205\u20131213.","journal-title":"J Histochem Cytochem"},{"key":"BFtp20163_CR21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-neuro-061010-113641","volume":"34","author":"CR Gerfen","year":"2011","unstructured":"Gerfen CR, Surmeier DJ . Modulation of striatal projection systems by dopamine. Annu Rev Neurosci 2011; 34: 441\u2013466.","journal-title":"Annu Rev Neurosci"},{"key":"BFtp20163_CR22","doi-asserted-by":"publisher","first-page":"e106768","DOI":"10.1371\/journal.pone.0106768","volume":"9","author":"WH Jung","year":"2014","unstructured":"Jung WH, Jang JH, Park JW, Kim E, Goo EH, Im OS et al. Unravelling the intrinsic functional organization of the human striatum: a parcellation and connectivity study based on resting-state FMRI. PLoS One 2014; 9: e106768.","journal-title":"PLoS One"},{"key":"BFtp20163_CR23","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.neuron.2008.11.005","volume":"60","author":"AC Kreitzer","year":"2008","unstructured":"Kreitzer AC, Malenka RC . Striatal plasticity and basal ganglia circuit function. Neuron 2008; 60: 543\u2013554.","journal-title":"Neuron"},{"key":"BFtp20163_CR24","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1111\/j.1476-5381.2011.01729.x","volume":"165","author":"T Keravis","year":"2012","unstructured":"Keravis T, Lugnier C . Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments. Br J Pharmacol 2012; 165: 1288\u20131305.","journal-title":"Br J Pharmacol"},{"key":"BFtp20163_CR25","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1006\/bbrc.1999.1013","volume":"261","author":"J Kotera","year":"1999","unstructured":"Kotera J, Fujishige K, Yuasa K, Omori K . Characterization and phosphorylation of PDE10A2, a novel alternative splice variant of human phosphodiesterase that hydrolyzes cAMP and cGMP. Biochem Biophys Res Commun 1999; 261: 551\u2013557.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFtp20163_CR26","doi-asserted-by":"publisher","first-page":"5943","DOI":"10.1046\/j.1432-1327.2000.01661.x","volume":"267","author":"K Fujishige","year":"2000","unstructured":"Fujishige K, Kotera J, Yuasa K, Omori K . The human phosphodiesterase PDE10A gene genomic organization and evolutionary relatedness with other PDEs containing GAF domains. Eur J Biochem 2000; 267: 5943\u20135951.","journal-title":"Eur J Biochem"},{"key":"BFtp20163_CR27","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.cell.2012.03.028","volume":"149","author":"M Talkowski","year":"2012","unstructured":"Talkowski M, Rosenfeld J, Blumenthal I, Pillalamarri V, Chiang C, Heilbut A et al. Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell 2012; 149: 525\u2013537.","journal-title":"Cell"},{"key":"BFtp20163_CR28","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1074\/jbc.M308471200","volume":"279","author":"J Kotera","year":"2004","unstructured":"Kotera J, Sasaki T, Kobayashi T, Fujishige K, Yamashita Y, Omori K . Subcellular localization of cyclic nucleotide phosphodiesterase type 10A variants, and alteration of the localization by cAMP-dependent protein kinase-dependent phosphorylation*. J Biol Chem 2004; 279: 4366\u20134375.","journal-title":"J Biol Chem"},{"key":"BFtp20163_CR29","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.neuroscience.2005.12.042","volume":"139","author":"Z Xie","year":"2006","unstructured":"Xie Z, Adamowicz WO, Eldred WD, Jakowski AB, Kleiman RJ, Morton DG et al. Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiestease. Neuroscience 2006; 139: 597\u2013607.","journal-title":"Neuroscience"},{"key":"BFtp20163_CR30","doi-asserted-by":"publisher","first-page":"9027","DOI":"10.1523\/JNEUROSCI.1635-10.2010","volume":"30","author":"EI Charych","year":"2010","unstructured":"Charych EI, Jiang L-X, Lo F, Sullivan K, Brandon NJ . Interplay of palmitoylation and phosphorylation in the trafficking and localization of phosphodiesterase 10A: implications for the treatment of schizophrenia. J Neuroscience 2010; 30: 9027\u20139037.","journal-title":"J Neuroscience"},{"key":"BFtp20163_CR31","doi-asserted-by":"publisher","first-page":"7272","DOI":"10.1523\/JNEUROSCI.2306-04.2004","volume":"24","author":"G Stefani","year":"2004","unstructured":"Stefani G, Fraser CE, Darnell JC, Darnell RB . Fragile X mental retardation protein is associated with translating polyribosomes in neuronal cells. J Neurosci 2004; 24: 7272\u20137276.","journal-title":"J Neurosci"},{"key":"BFtp20163_CR32","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1261\/rna.79407","volume":"13","author":"MJ del Prete","year":"2007","unstructured":"del Prete MJ, Vernal R, Dolznig H, Mullner EW, Garcia-Sanz JA . Isolation of polysome-bound mRNA from solid tissues amenable for RT-PCR and profiling experiments. RNA 2007; 13: 414\u2013421.","journal-title":"RNA"},{"key":"BFtp20163_CR33","doi-asserted-by":"publisher","first-page":"7275","DOI":"10.1523\/JNEUROSCI.6476-10.2011","volume":"31","author":"S Wang","year":"2011","unstructured":"Wang S, Cesca F, Loers G, Schweizer M, Buck F, Benfenati F et al. Synapsin I is an oligomannose-carrying glycoprotein, acts as an oligomannose-binding lectin, and promotes neurite outgrowth and neuronal survival when released via glia-derived exosomes. J Neurosci 2011; 31: 7275\u20137290.","journal-title":"J Neurosci"},{"key":"BFtp20163_CR34","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/j.1471-4159.2010.06957.x","volume":"115","author":"JR Dodd","year":"2010","unstructured":"Dodd JR, Birch NP, Waldvogel HJ, Christie DL . Functional and immunocytochemical characterization of the creatine transporter in rat hippocampal neurons. J Neurochem 2010; 115: 684\u2013693.","journal-title":"J Neurochem"},{"key":"BFtp20163_CR35","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1152\/physrev.1995.75.4.725","volume":"75","author":"JA Beavo","year":"1995","unstructured":"Beavo JA . Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995; 75: 725\u2013748.","journal-title":"Physiol Rev"},{"key":"BFtp20163_CR36","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1201\/9781420020847-12","volume-title":"Cyclic Nucleotide Phosphodiesterases in Health and Disease","author":"CA Strick","year":"2006","unstructured":"Strick CA, Schmidt CJ, Menniti FS . PDE10A: a striatum-enriched, dual-substrate phosphodiesterase. In: Beavo J, Francis S, Houslay M (eds). Cyclic Nucleotide Phosphodiesterases in Health and Disease. CRC Press: Boca Raton, FL, USA, 2006, pp 237\u2013254."},{"key":"BFtp20163_CR37","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1101\/gad.1026202","volume":"16","author":"JE Butler","year":"2002","unstructured":"Butler JE, Kadonaga JT . The RNA polymerase II core promoter: a key component in the regulation of gene expression. Genes Dev 2002; 16: 2583\u20132592.","journal-title":"Genes Dev"},{"key":"BFtp20163_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7007-8-149","volume":"8","author":"P Kapranov","year":"2010","unstructured":"Kapranov P, Laurent GS, Raz T, Ozsolak F, Reynolds CP, Sorensen PH et al. The majority of total nuclear-encoded non-ribosomal RNA in a human cell is \u2018dark matter\u2019 un-annotated RNA. BMC Biol 2010; 8: 1\u201315.","journal-title":"BMC Biol"},{"key":"BFtp20163_CR39","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1038\/nsmb.2143","volume":"18","author":"A Ameur","year":"2011","unstructured":"Ameur A, Zaghlool A, Halvardson J, Wetterbom A, Gyllensten U, Cavelier L et al. Total RNA sequencing reveals nascent transcription and widespread co-transcriptional splicing in the human brain. Nat Struct Mol Biol 2011; 18: 1435\u20131440.","journal-title":"Nat Struct Mol Biol"},{"key":"BFtp20163_CR40","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1042\/bj20021082","volume":"370","author":"M Shepherd","year":"2003","unstructured":"Shepherd M, McSorley T, Olsen AE, Johnston LA, Thomson NC, Baillie GS et al. Molecular cloning and subcellular distribution of the novel PDE4B4 cAMP-specific phosphodiesterase isoform. Biochem J 2003; 370: 429\u2013438.","journal-title":"Biochem J"},{"key":"BFtp20163_CR41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0006-8993(03)02754-9","volume":"985","author":"TF Seeger","year":"2003","unstructured":"Seeger TF, Bartlett B, Coskran TM, Culp JS, James LC, Krull DL et al. Immunohistochemical localization of PDE10A in the rat brain. Brain Res 2003; 985: 113\u2013126.","journal-title":"Brain Res"},{"key":"BFtp20163_CR42","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.neuropharm.2006.01.012","volume":"51","author":"JA Siuciak","year":"2006","unstructured":"Siuciak JA, McCarthy SA, Chapin DS, Fujiwara RA, James LC, Williams RD et al. Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: evidence for altered striatal function. Neuropharmacology 2006; 51: 374\u2013385.","journal-title":"Neuropharmacology"},{"key":"BFtp20163_CR43","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.coph.2006.08.014","volume":"1","author":"A Hebb","year":"2007","unstructured":"Hebb A, Robertson H . Role of phosphodiesterases in neurological and psychiatric disease. Curr Opin Pharmacol 2007; 1: 86\u201392.","journal-title":"Curr Opin Pharmacol"},{"key":"BFtp20163_CR44","doi-asserted-by":"publisher","first-page":"378","DOI":"10.2174\/1381612820666140826114744","volume":"21","author":"LS Wilson","year":"2014","unstructured":"Wilson LS, Brandon NJ . Emerging biology of PDE10A. Curr Pharm Des 2014; 21: 378\u2013388.","journal-title":"Curr Pharm Des"},{"key":"BFtp20163_CR45","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.neuropharm.2006.04.013","volume":"51","author":"J Siuciak","year":"2006","unstructured":"Siuciak J, Chapin D, Harms J, Lebel L, McCarthy S, Chambers L et al. Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis. Neuropharmacology 2006; 51: 386\u2013396.","journal-title":"Neuropharmacology"},{"key":"BFtp20163_CR46","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1124\/pr.58.3.5","volume":"58","author":"A Bender","year":"2006","unstructured":"Bender A, Beavo J . Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 2006; 58: 488\u2013520.","journal-title":"Pharmacol Rev"},{"key":"BFtp20163_CR47","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1152\/physrev.00030.2010","volume":"91","author":"SH Francis","year":"2011","unstructured":"Francis SH, Blount MA, Corbin JD . Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions. Physiol Rev 2011; 91: 651\u2013690.","journal-title":"Physiol Rev"},{"key":"BFtp20163_CR48","doi-asserted-by":"publisher","first-page":"19657","DOI":"10.1074\/jbc.M800595200","volume":"283","author":"N Handa","year":"2008","unstructured":"Handa N, Mizohata E, Kishishita S, Toyama M, Morito S, Uchikubo-Kamo T et al. Crystal structure of the GAF-B domain from human phosphodiesterase 10A complexed with its ligand, cAMP. J Biol Chem 2008; 283: 19657\u201319664.","journal-title":"J Biol Chem"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tp20163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp20163","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp20163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T08:42:15Z","timestamp":1672821735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp20163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,23]]},"references-count":48,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2]]}},"alternative-id":["BFtp20163"],"URL":"https:\/\/doi.org\/10.1038\/tp.2016.3","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,23]]},"assertion":[{"value":"18 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}